A study presented at ENDO 2022 laid bare the excess direct healthcare costs of mental health disorders associated with polycystic ovary syndrome (PCOS) in the United States, finding those costs reached almost $6 billion in 2021. The authors of the study point out that PCOS affects one in seven reproductive-aged women worldwide, and represents a...
At ENDO 2022, scientists and researchers flocked to the session, “The Business of Starting and Running a Lab,” which covered everything a new PI needs to know from hiring and managing a staff to preparing budgets and even managing your own time. Endocrine News spoke to that session’s speakers and other experts for the “secrets...
Amidst of the throngs of ENDO 2022 attendees, Olympian Gail Devers took centerstage to discuss living with and overcoming Graves’ disease and thyroid eye disease. She teamed up with endocrinologist Eve D. Bloomgarden, MD, to tout the importance of patient/physician teamwork and why patients need to champion their own healthcare. In a lot of ways,...
A study presented at ENDO 2022 in Atlanta this past summer suggests that active testosterone therapy for transgender men may negatively impact IVF outcomes. Research presented by Amanda Schwartz, MD, a reproductive endocrinology and infertility fellow at the University of Michigan, found that female mice currently receiving testosterone had fewer and less developed eggs retrieved....
Two Endocrine Society staff members were honored with Association Forum’s 2022 Forty Under 40 Awards. Rodneikka Scott, CAE, and Caitlin Couture, CAE, were selected based on their extraordinary career accomplishments, commitment to the industry, and their continued pursuit to advance the professional practice of association management, and they represent the nation’s top 40 professionals from...
ENDO 2022 was once again a hotbed of new research as people convened in person and online from around the world. Here, we look at two international researchers who shared their COVID-19 studies in poster presentations that looked at the pandemic’s impact on thyroid function, thyroid dysfunction, and the impact on women’s ovulatory cycles. ENDO...
Study only finds this association in women with excessive weight gain during pregnancy Children of women with gestational diabetes and obesity may be twice as likely to develop attention-deficit/hyperactivity disorder (ADHD) compared to those whose mothers did not have obesity, according to new research published in The Journal of Clinical Endocrinology & Metabolism. The estimated number of children...
Women who are longer-term survivors of metastatic breast cancer may have a worse survival rate if they have diabetes and poorly controlled blood sugar levels, according to a study presented at ENDO 2022. The authors of the study point out that a well-established relationship between diabetes and breast cancer exists, but it’s still unclear how...
Amidst of the throngs of ENDO 2022 attendees, Olympian Gail Devers took centerstage to discuss living with and overcoming Graves’ disease and thyroid eye disease. She teamed up with endocrinologist Eve D. Bloomgarden, MD, to tout the importance of patient/physician teamwork and why patients need to champion their own healthcare. In a lot of ways,...
